tiopronin

FDA Drug Profile — TIOPRONIN, VENXXIVA, tiopronin, Thiola EC, Thiola

tiopronin is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including TIOPRONIN, VENXXIVA, tiopronin. Available dosage forms: tablet, delayed release, tablet, sugar coated.

Drug Details

Generic Name
tiopronin
Brand Names
TIOPRONIN, VENXXIVA, tiopronin, Thiola EC, Thiola
Application Number
ANDA216990
Sponsor
Torrent Pharmaceuticals Limited
NDC Codes
8
Dosage Forms
TABLET, DELAYED RELEASE, TABLET, SUGAR COATED
Routes
ORAL
Active Ingredients
TIOPRONIN

Indications and Usage

1 INDICATIONS AND USAGE Tiopronin delayed-release tablets are indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria, who are not responsive to these measures alone. Additional pediatric use information is approved for Mission Pharmacal Company’s Thiola EC (tiopronin delayed-release) tablets. However, due to Mission Pharmacal Company’s marketing exclusivity rights, this drug product is not labeled with that information. Tiopronin delayed-release tablets are a reducing and complexing thiol indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria, who are not responsive to these measures alone. ( 1 )